Samuel George A. III (CIK 0001878732)

Latest company ownership

LCTX - Lineage Cell Therapeutics, Inc.

Role: General Counsel and Secretary

Shares held

6,076

Last filed at

Feb 12, 2025

Confidence Score

76.3

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 19, 2025	Dec 19, 2025	Lineage Cell Therapeutics, Inc.	General Counsel and Secretary	Sell	85.0	+1,670	6.47%	✗	$109.2
Feb 11, 2025	Feb 12, 2025	Lineage Cell Therapeutics, Inc.	General Counsel	Sell	47.5	-2,440	-8.63%	✗	$1.6K
Nov 26, 2024	Nov 26, 2024	Lineage Cell Therapeutics, Inc.	General Counsel	Buy	90.0	+15,000	208.80%	✗	$9K
Feb 11, 2024	Feb 12, 2024	Lineage Cell Therapeutics, Inc.	General Counsel/Secretary	Sell	47.5	-2,490	-25.74%	✗	$2.7K
Feb 11, 2023	Feb 14, 2023	Lineage Cell Therapeutics, Inc.	General Counsel/Secretary	Sell	47.5	-2,478	-40.78%	✗	$3.3K